The leading Biotechnology firm of India, Biocon has announced it's fourth quarter financial results. Biocon is basically known for its outlined services on diabetes, cancer and auto-immune diseases etc. The Bio firm has managed to register an impressive net profit. The company has made a profit of Rs 80.6 crore in this quarter.

During January to March this year the net profit has raised sharply as there was a huge increases in revenue. There was a forex loss of Rs 41.4 crore as well.

Biocon has informed that it has posted a profit of Rs 80.6 crore in this quarter. The sales figure of the company during this period was also remarkable. It has jumped up to Rs 656.8 crore which is a hike of 40.9% from the previous quarter. The board of Directors of Biocon has decided to recommend a dividend of Rs 3.50 per equity share for its investors.

So far as the consolidated net profit of the company is concerned, it has been increased to 215% to Rs 293.3 crore for the current fiscal year.